Delivery Order SPE2DR25D6028-SPE2DR26FARRZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Gabapentin 600 mg tablets (500-count units) with a contract value of $1,413.84. This is a firm fixed price delivery order with an ultimate completion date of September 25, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Gabapentin 800 mg tablets in quantities of 500, with a contract ceiling value of $1,007.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 5, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Gabapentin 600 mg, with a firm fixed price ceiling value of $1,294.68. The order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-competitive delivery order represents pharmaceutical procurement from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of 1,000 units of Gabapentin 300 mg capsules at a ceiling value of $1,982.22. This non-set-aside competitive award is scheduled for completion by October 30, 2025, with performance fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,841.36 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Gabapentin 600 mg tablets in quantities of 500 units. This firm fixed-price contract, with a completion date of July 11, 2025, is classified as a child contract and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this delivery. The...
- The Defense Logistics Agency awarded a $1,153.82 delivery order to AmerisourceBergen Drug Corp for the supply of Gabapentin 800 mg tablets (500-count units) with an ultimate completion date of November 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order is a child...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 800 mg gabapentin tablets. The $3,227.98 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,194.37 by the Defense Logistics Agency for 500 tablets of Gabapentin 600 mg. The contract was competitively awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred seven dollars and forty-five cents to Amerisourcebergen Drug Corporation for gabapentin tablets. As the prime contractor, Amerisourcebergen will supply ninety tablets of six-hundred milligram gabapentin to fulfill requirements under the order. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on September 29, 2023. The Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565442175 Gabapentin 800 mg tablets. The $2,527.06 firm-fixed-price contract has an estimated completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARRZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Gabapentin 300mg tablets (1,000 count) with a ceiling value of $3,686.74. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Gabapentin delivery represents a routine procurement of a generic neurological medication supporting the Defense Health Agency and other federal healthcare systems' inventory requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/14/25 |